Nebulized Heparin to Reduce COVID-19-induced Acute Lung Injury: A Prospective Observational Study
Description
CONCLUSION: Administration of nebulized heparin in COVID-19 pneumonia with mild ARDS may improve oxygenation and result in the improvement of inflammatory markers with variable sensitivity and specificity.
